-
Biogen’s inherited eye disease gene therapy misses the mark in late-stage trial
pharmatimes
June 17, 2021
Biogen has announced that a late-stage trial of its gene therapy timrepigene emparvovec did not meet its primary and key secondary endpoints in patients with the rare inherited eye disease choroideremia.
-
AI could identify existing drugs to help treat eye disease
pharmatimes
April 16, 2019
The data from research collaboration Action Against Age-related macular degeneration……
-
Verily/Google use algorithm to detect diabetic eye disease
pharmaphorum
February 27, 2019
Verily and Google have developed a machine learning algorithm that can automatically detect diabetes-related eye disease, which could be used to take pressure off services in countries where the condition is becoming more common.
-
2 studies use retinal scans to potentially identify earlier signs of Alzheimer’s disease
fiercebiotech
November 02, 2018
Two studies showed that noninvasive eye scans measuring the thickness of the retina can provide a window into the early signs of Alzheimer’s disease, with the goal of providing a quick, inexpensive...
-
Eye Disease Link to Alzheimer's Seen
drugs
August 13, 2018
Researchers have discovered a link between three degenerative eye diseases and Alzheimer's disease.
-
Ophthotech completes clean sweep of phase 3 trial flops
fiercebiotech
August 15, 2017
This is yet another flop for the eye disease biotech.
-
Stem Cells Hold Promise, Peril in Treating Seniors' Eye Disease
drugs.com
March 16, 2017
Stem cells may offer new hope for people losing their vision to age-related macular degeneration, but that promise can come with some peril, new research shows.